Beam Therapeutics Inc
(BEAM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 12-2010 | 12-2009 | 12-2008 | 12-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 218,300 | 811,500 | 417,200 | 163,300 | 203,700 |
| Receivables | 385,800 | 431,100 | 949,000 | 918,500 | 1,101,900 |
| Inventories | 1,551,500 | 1,523,100 | 2,016,600 | 1,975,400 | 2,047,600 |
| Other current assets | 278,800 | 1,577,300 | 488,900 | 410,900 | 427,700 |
| TOTAL | $2,434,400 | $4,343,000 | $3,871,700 | $3,468,100 | $3,780,900 |
| Non-Current Assets | |||||
| PPE Net | 729,700 | 668,200 | 1,467,900 | 1,553,900 | 1,698,200 |
| Investments And Advances | 42,200 | 51,900 | 49,800 | 55,100 | 110,000 |
| Intangibles | 4,202,900 | 4,364,300 | 6,764,900 | 6,783,200 | 8,063,200 |
| Other Non-Current Assets | 82,600 | 3,246,600 | 216,299 | 231,600 | 304,600 |
| TOTAL | $5,057,400 | $8,331,000 | $8,498,899 | $8,623,800 | $10,176,000 |
| Total Assets | $7,491,800 | $12,674,000 | $12,370,600 | $12,091,900 | $13,956,900 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 0 | 5,000 | 200,000 |
| Accounts payable and accrued liabilities | 206,100 | 189,300 | 468,500 | 387,700 | 468,900 |
| Other current liabilities | 524,200 | 521,000 | 943,800 | 765,800 | 1,194,000 |
| TOTAL | $758,700 | $2,106,900 | $1,463,600 | $1,190,100 | $2,093,900 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,902,100 | 3,620,600 | 4,413,300 | 4,688,600 | 3,942,700 |
| Other Non-Current Liabilities | 352,100 | 857,001 | 740,799 | 879,400 | 1,193,900 |
| TOTAL | $2,633,400 | $4,879,101 | $5,801,299 | $6,202,200 | $6,177,500 |
| Total Liabilities | $3,392,100 | $6,986,000 | $7,264,900 | $7,392,300 | $8,271,400 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 156,721 | 153,422 | 151,978 | 150,151 | 154,031 |
| Common Shares | 734,000 | 734,000 | 734,000 | 734,000 | 734,000 |
| Retained earnings | 5,892,600 | 7,499,300 | 7,135,400 | 7,046,200 | 6,999,300 |
| Other shareholders' equity | -299,300 | -150,500 | -193,300 | -459,000 | 354,900 |
| TOTAL | $4,099,700 | $5,688,000 | $5,105,700 | $4,699,600 | $5,685,500 |
| Total Liabilities And Equity | $7,491,800 | $12,674,000 | $12,370,600 | $12,091,900 | $13,956,900 |